The UAE Cabinet recently made a pivotal decision to form the board of directors for the Emirates Drug Establishment, a […]
In a recent development, Dr. Mansukh Mandaviya, the Union Health and Family Welfare Minister, along with his responsibilities as the […]
International Finance Corporation (IFC), a member of the World Bank is lending $147.5 million (around Rs.866 crore) to Jubilant Pharma […]
The commission has also recommended a GPS based sample collection systems and online applications for licensing New Delhi: The Planning […]
After much hullabaloo the Foreign Direct Investment (FDI) policy for Pharma may get reconsideration. As per a senior finance minister […]
Kewal Handa Managing Director, Pfizer Ltd Kewal Handa is recognised as an industry expert on issues concerning the pharmaceutical sector. […]
Piramal Healthcare, which specialises in contract manufacturing and over-the-counter drugs, is looking to raise its research and development spend to […]
QuantumID Technologies, a key player in the RFID (Radio Frequency Identification) segment, is coming with an RFID solution for the pharmaceutical sector. The product would be developed at its R&D centre in Pune, India.
The research-based pharma companies are mounting pressure for stronger regulatory data protection laws.
Project Connect, funded by United States Agency for International Development (USAID), a five year program launched by Population Services International (PSI) in association with Federation of Indian Chambers of Commerce and Industry (FICCI), organised a national symposium on,
Indian pharmaceutical companies welcome in China for meeting their growing domestic demands.
With a view to promote research and development in the pharmaceutical sector, the government plans to provide soft loans of INR 100 crore to the industry in the current fiscal.
A latest Ernst & Young survey of Chief financial officers (CFOs) in the Indian pharmaceutical sector underscores important changes in the role of the CFO and the finance function in driving the success of pharmaceutical companies. Respondents of the India CFO survey envisaged a change in their responsibilities, with an increased focus on serving as business partners and managing growth.